Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycin

Author(s):

Adrianna M. Turner, Lucy Li, Ian R. Monk, Jean Y.H. Lee, Danielle J. Ingle, Stephanie Portelli, Norelle L. Sherry, Nicole Isles, Torsten Seemann, Liam K. Sharkey, Calum J. Walsh, Gavin E. Reid, Shuai Nie, Bart A. Eijkelkamp, Natasha E. Holmes, Brennan Collis, Sara Vogrin, Andreas Hiergeist, Daniela Weber, Andre Gessner, Ernst Holler, David B. Ascher, Sebastian Duchene, Nichollas E. Scott, Timothy P. Stinear, Jason C. Kwong, Claire L. Gorrie, Benjamin P. Howden, Glen P. Carter

Details:

Nature, 2024-01-01

Article Link: Click here

Affiliations:

• The Peter Doherty Institute for Infection and Immunity
• University of Melbourne
• Bio21 Molecular Science and Biotechnology Institute
• Klinikum der Universität Regensburg und Medizinische Fakultät
• College of Science and Engineering
• School of Chemistry
• Baker Heart and Diabetes Institute
• The University of Queensland
• Monash Health
• Austin Health
• Institut Pasteur, Paris